To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TLE2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
232 supporting clones for gene TLE2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK293407 bladder .a 1 to 2107 2 to 2110 S259G tiling clone,   2110/2110
(100 %)
5 diff
(99.8 %id)
NM_001144762.1   .a 1 to 2280 2 to 2281 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2281/2281
(100 %)
0 diff
(100 %id)
DA046062 bladder .a 1 to 575 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
TI_1948148431   .a 1090 to 2070 1108 to 129       980/1426
(68 %)
38 diff
(97.4 %id)
TI_1948148729   .a 1108 to 2070 1088 to 127       962/1354
(71 %)
32 diff
(97.7 %id)
BU190085 leiomyosarcoma, uterus .a 1112 to 2002 5 to 902       898/904
(99 %)
24 diff
(97.4 %id)
TI_1948149365   .a 1122 to 2070 1078 to 127       952/1495
(63 %)
58 diff
(96.2 %id)
TI_1948149032   .a 1128 to 2070 1057 to 128       930/1268
(73 %)
20 diff
(98.5 %id)
TI_1948148730   .a 1152 to 2070 1039 to 128       912/1440
(63 %)
42 diff
(97.1 %id)
TI_1948149364   .a 1156 to 2070 1022 to 128       895/1262
(70 %)
33 diff
(97.4 %id)
TI_1948148430   .a 1225 to 2070 972 to 129       844/1340
(62 %)
5 diff
(99.7 %id)
TI_1948149033   .a 1228 to 2070 974 to 127       848/1425
(59 %)
25 diff
(98.3 %id)
BM048341 carcinoma, cell line, Prostate .a 1300 to 1967 1 to 667       667/667
(100 %)
2 diff
(99.8 %id)
TI_149277869   .a 1332 to 2274 1022 to 86   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 937/1084
(86 %)
31 diff
(97.2 %id)
BM789826 stomach .a 1344 to 1934 1 to 591       591/591
(100 %)
0 diff
(100 %id)
AA047472 uterus .a 1358 to 1707 1 to 351       351/360
(97 %)
19 diff
(94.8 %id)
BX105520 uterus .a 1360 to 2056 1 to 697       697/697
(100 %)
0 diff
(100 %id)
TI_151750101   .a 1412 to 2182 971 to 195   AAA   777/1104
(70 %)
59 diff
(94.7 %id)
TI_149312066   .a 1429 to 2280 928 to 83   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 846/975
(86 %)
7 diff
(99.3 %id)
H25976 breast .a 1445 to 1616 1 to 172       172/172
(100 %)
0 diff
(100 %id)
BM466005 eye, retinoblastoma .a 1447 to 2279 26 to 861       836/1035
(80 %)
19 diff
(98.2 %id)
TI_149288390   .a 1474 to 2274 873 to 80   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 794/966
(82 %)
23 diff
(97.7 %id)
CA313714 Human Lung Epithelial cells, lung .a 1495 to 2280 802 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 784/784
(100 %)
4 diff
(99.5 %id)
BU633269 cell lines, Chondrosarcoma .a 1522 to 2272 768 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 750/753
(99 %)
1 diff
(99.9 %id)
R53387 breast .a 1524 to 1850 1 to 331       331/352
(94 %)
8 diff
(97.8 %id)
BM977785 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1536 to 2280 762 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 744/744
(100 %)
1 diff
(99.9 %id)
BQ575409 Chondrosarcoma Grade II, Left Pelvis .a 1567 to 2272 724 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 706/706
(100 %)
1 diff
(99.9 %id)
TI_149290488   .a 1588 to 2272 762 to 85   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 678/918
(73 %)
12 diff
(98.7 %id)
BM931931 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1596 to 1994 1 to 399   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
BM700654 eye, eye anterior segment .a 1606 to 1963 9 to 366       358/375
(95 %)
6 diff
(98.4 %id)
AA714867 Ewing's sarcoma .a 1614 to 2084 8 to 481       474/481
(98 %)
23 diff
(95.3 %id)
BU678020 lung .a 1615 to 2274 676 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 660/660
(100 %)
1 diff
(99.9 %id)
R55062 breast .a 1621 to 1769 1 to 149       149/149
(100 %)
3 diff
(98.0 %id)
TI_151713356   .a 1658 to 2280 719 to 96   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 624/1176
(53 %)
6 diff
(99.5 %id)
AI937052 anaplastic oligodendroglioma, brain .a 1659 to 2280 639 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 621/624
(99 %)
13 diff
(98.0 %id)
AW874352 tumor, uterus .a 1685 to 2272 588 to 1       588/588
(100 %)
3 diff
(99.5 %id)
BM973476 lung .a 1694 to 2272 597 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 579/579
(100 %)
2 diff
(99.7 %id)
AI697342 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1700 to 2277 576 to 1       576/576
(100 %)
8 diff
(98.7 %id)
CK902320 Pancreas, Purified pancreatic islet .a 1706 to 2231 526 to 1     Submitted on the opposite strand 526/526
(100 %)
0 diff
(100 %id)
AI721133 colon .a 1713 to 2268 557 to 3       555/557
(99 %)
10 diff
(98.3 %id)
DW420889 Liver .a 1730 to 2017 12 to 299       290/299
(96 %)
12 diff
(96.0 %id)
DW465231 Liver .a 1730 to 2077 12 to 359       350/359
(97 %)
9 diff
(97.5 %id)
AA471015 colon .a 1731 to 2275 547 to 1       547/568
(96 %)
18 diff
(96.9 %id)
AI420901 Prostate .a 1733 to 2084 214 to 565     Submitted on the opposite strand 355/565
(62 %)
6 diff
(99.0 %id)
BU681365 lung .a 1750 to 2274 540 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 524/524
(100 %)
1 diff
(99.9 %id)
AI869050 Prostate .a 1756 to 2274 539 to 20   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 520/520
(100 %)
21 diff
(96.0 %id)
CA311689 Human Lung Epithelial cells, lung .a 1758 to 2274 533 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 517/517
(100 %)
1 diff
(99.9 %id)
BE857057 brain, glioblastoma (pooled) .a 1763 to 2273 513 to 3       511/513
(99 %)
8 diff
(98.5 %id)
BE328177 carcinoid, lung .a 1764 to 2273 510 to 1       510/510
(100 %)
2 diff
(99.7 %id)
BG015130 placenta_normal .a 1775 to 2163 11 to 399       389/402
(96 %)
13 diff
(96.8 %id)
AI127832 uterus .a 1778 to 2272 495 to 1       495/495
(100 %)
2 diff
(99.6 %id)
BP383891 pancreatic islet .a 1783 to 2275 1 to 494     Submitted on the opposite strand 494/499
(98 %)
2 diff
(99.6 %id)
AI870151 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1784 to 2275 497 to 4       494/497
(99 %)
14 diff
(97.2 %id)
TI_151742571   .a 1786 to 2274 598 to 107   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 492/552
(89 %)
11 diff
(98.1 %id)
BQ787990 Pancreas, Purified pancreatic islet .a 1816 to 2273 459 to 2       458/459
(99 %)
0 diff
(100 %id)
AA507034 breast .a 1817 to 2274 457 to 1       457/460
(99 %)
12 diff
(97.4 %id)
AW081722 colon, moderately differentiated adenocarcinoma .a 1818 to 2275 457 to 2       456/457
(99 %)
2 diff
(99.6 %id)
AW081723 colon, moderately differentiated adenocarcinoma .a 1818 to 2274 474 to 20   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 455/455
(100 %)
4 diff
(99.2 %id)
AA037755 uterus .a 1823 to 2222 407 to 1       407/412
(98 %)
13 diff
(96.9 %id)
AI681385 carcinoid, lung .a 1826 to 2275 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI337092 pooled germ cell tumors .a 1837 to 2275 447 to 8       440/447
(98 %)
9 diff
(98.0 %id)
AA047433 uterus .a 1842 to 2274 432 to 1       432/433
(99 %)
1 diff
(99.8 %id)
AA961098 carcinoid, lung .a 1857 to 2272 416 to 1       416/416
(100 %)
2 diff
(99.6 %id)
AI422662 Prostate .a 1862 to 2211 353 to 1       353/353
(100 %)
8 diff
(97.8 %id)
AA873564 Kidney .a 1873 to 2275 407 to 6       402/407
(98 %)
1 diff
(99.8 %id)
R55032 breast .a 1881 to 2272 393 to 1       393/420
(93 %)
6 diff
(98.6 %id)
H25942 breast .a 1886 to 2069 184 to 1       184/196
(93 %)
12 diff
(93.9 %id)
CO399498 Chondrosarcoma Lung Metastasis cell lines, lung .a 1888 to 2272 1 to 385   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 385/385
(100 %)
5 diff
(98.8 %id)
DW446534 Liver .a 1898 to 2098 16 to 216       201/216
(93 %)
6 diff
(97.3 %id)
R53986 breast .a 1929 to 2272 343 to 1       343/343
(100 %)
2 diff
(99.5 %id)
BM684978 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1933 to 2274 358 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 342/342
(100 %)
0 diff
(100 %id)
AA100631 brain, neuroepithelial cells .b 1 to 388 6 to 399   tiling clone,   399/400
(99 %)
6 diff
(98.5 %id)
BM692612 eye, human retina .b 346 to 879 1 to 534   tiling clone, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 534/534
(100 %)
2 diff
(99.7 %id)
CD517400 White Matter .b 758 to 1591 1 to 844   tiling clone,   844/922
(91 %)
16 diff
(98.3 %id)
BM663833 eye, human retina .b 1462 to 2036 591 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 575/575
(100 %)
0 diff
(100 %id)
AA100632 brain, neuroepithelial cells .b 1613 to 2009 403 to 1       403/403
(100 %)
8 diff
(98.1 %id)
AA604974   .b 1622 to 1725 1 to 104       104/124
(83 %)
5 diff
(96.0 %id)
CA398013 eye, RPE/choroid .c 1 to 637 1 to 637   tiling clone, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 637/637
(100 %)
1 diff
(99.9 %id)
AK308608 cerebellum .c 116 to 1064 1 to 969   tiling clone,   969/969
(100 %)
11 diff
(98.9 %id)
BQ777299 Pancreas, Purified pancreatic islet .c 128 to 671 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
CK902319 Pancreas, Purified pancreatic islet .c 142 to 694 1 to 553     Submitted on the opposite strand 553/553
(100 %)
4 diff
(99.3 %id)
DA630267 Kidney .c 333 to 877 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
CA398012 eye, RPE/choroid .c 2185 to 2655 487 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
AK293482 cerebellum .d 1 to 2471 2 to 2492 exact tiling clone,   2492/2492
(100 %)
12 diff
(99.6 %id)
DA058071 cerebellum .d 1 to 577 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA923140 small intestine .d 65 to 618 2 to 556   tiling clone, capped   555/555
(100 %)
3 diff
(99.5 %id)
DA066725 cerebellum .d 428 to 919 2 to 512   capped   511/511
(100 %)
11 diff
(97.9 %id)
DB059446 testis .d 547 to 931 2 to 406   capped   405/405
(100 %)
10 diff
(97.6 %id)
CA391534 eye, RPE/choroid .e 1 to 600 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
BM705253 eye, RPE and Choroid .e 67 to 635 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DA598488   .e 283 to 855 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
TI_59390478   .e 299 to 1012 97 to 814       718/720
(99 %)
24 diff
(96.7 %id)
TI_59390815   .e 299 to 846 98 to 650       553/714
(77 %)
17 diff
(97.7 %id)
TI_59390899   .e 299 to 782 104 to 584       481/481
(100 %)
3 diff
(99.4 %id)
BM020037 astrocytoma grade IV, cell line, brain .e 300 to 846 1 to 552       552/713
(77 %)
17 diff
(97.7 %id)
BM020119 astrocytoma grade IV, cell line, brain .e 300 to 782 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
BM019783 astrocytoma grade IV, cell line, brain .e 301 to 1012 1 to 717       717/719
(99 %)
25 diff
(96.6 %id)
BM913650 astrocytoma grade IV, cell line, brain .e 302 to 753 1 to 452       452/1213
(37 %)
6 diff
(99.6 %id)
BI046298 prostate_normal .e 574 to 1181 609 to 1       609/609
(100 %)
5 diff
(99.2 %id)
DA138385 alzheimer cortex .e 635 to 1205 2 to 572   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DA298065 hippocampus .f 1 to 561 2 to 583   tiling clone, capped   582/582
(100 %)
12 diff
(98.0 %id)
AU122032 mammary gland .f 58 to 727 2 to 692   tiling clone, capped   691/693
(99 %)
25 diff
(96.4 %id)
DB361328 mammary gland .f 1658 to 2201 545 to 1   tiling clone,   545/572
(95 %)
12 diff
(98.0 %id)
AI423920 brain, glioblastoma (pooled) .g 1 to 567 1 to 566   tiling clone, Submitted on the opposite strand 566/573
(98 %)
6 diff
(99.0 %id)
AW262763 brain, three pooled meningiomas .g 11 to 619 1 to 609     Submitted on the opposite strand 609/609
(100 %)
10 diff
(98.4 %id)
NM_003260.4   .g 11 to 2694 1 to 2704   RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2704/2704
(100 %)
10 diff
(99.7 %id)
DA126508 cerebellum .g 70 to 642 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CD616711   .g 78 to 451 1 to 374       374/374
(100 %)
1 diff
(99.8 %id)
CD616712   .g 78 to 613 547 to 13       535/547
(97 %)
2 diff
(99.7 %id)
BE735305 choriocarcinoma, placenta .g 147 to 758 34 to 649       616/1060
(58 %)
14 diff
(98.7 %id)
BC017364 Placenta, choriocarcinoma .g 154 to 2694 1 to 2561   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2561/2561
(100 %)
11 diff
(99.6 %id)
DB244809 uterus, tumor tissue .g 164 to 723 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA566339 heart .g 172 to 732 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA513177 brain .g 197 to 757 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA583644 lung .g 237 to 822 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BG979538 colon_normal .g 248 to 565 335 to 11       325/335
(97 %)
1 diff
(99.8 %id)
M99436 brain .g 249 to 2498 1 to 2271 G50D A104R L245P G246C R269G ...     2271/2271
(100 %)
29 diff
(98.8 %id)
CV027808 mixed .g 274 to 878 1 to 625       625/625
(100 %)
11 diff
(98.3 %id)
TI_1948148428   .g 274 to 796 125 to 649       525/1309
(40 %)
34 diff
(97.5 %id)
TI_1948148728   .g 274 to 1263 126 to 1158       1032/1391
(74 %)
58 diff
(95.9 %id)
TI_1948149030   .g 274 to 642 124 to 493       370/1368
(27 %)
10 diff
(99.3 %id)
TI_1948149031   .g 274 to 1260 128 to 1136       1009/1362
(74 %)
47 diff
(96.6 %id)
BP342964 stomach mucosa .g 438 to 1001 1 to 584       584/584
(100 %)
10 diff
(98.3 %id)
CD616710   .g 484 to 1126 1 to 662       662/667
(99 %)
13 diff
(98.1 %id)
BI522611 brain .g 648 to 1324 1 to 704       704/704
(100 %)
24 diff
(96.6 %id)
TI_44185376   .g 648 to 1324 34 to 737       704/737
(95 %)
18 diff
(97.6 %id)
BI523456 brain .g 1818 to 2610 798 to 1       798/807
(98 %)
24 diff
(97.1 %id)
TI_44185377   .g 1818 to 2610 798 to 1       798/807
(98 %)
24 diff
(97.1 %id)
DN996296 breast cancer, Mammary gland (cancer tissue) .h 1 to 670 1 to 670   tiling clone,   670/670
(100 %)
5 diff
(99.3 %id)
AK312285 cerebellum .h 25 to 2348 1 to 2344   tiling clone,   2344/2344
(100 %)
12 diff
(99.5 %id)
DA058235 cerebellum .h 26 to 577 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_57180886   .h 34 to 690 61 to 720       660/726
(90 %)
22 diff
(97.0 %id)
BI768619 pooled lung and spleen .h 41 to 690 1 to 654   tiling clone,   654/660
(99 %)
16 diff
(97.6 %id)
DA506063 brain .h 86 to 638 2 to 554   capped   553/554
(99 %)
1 diff
(99.9 %id)
DA591149 lung .h 97 to 663 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BE796613 lung, small cell carcinoma .h 109 to 637 1 to 546       468/546
(85 %)
16 diff
(97.1 %id)
TI_1948148429   .i 1 to 873 126 to 1001   tiling clone,   876/1360
(64 %)
17 diff
(98.8 %id)
TI_1948149363   .i 1 to 873 121 to 988       868/1316
(65 %)
21 diff
(98.5 %id)
CD616709   .i 211 to 929 728 to 10   tiling clone,   719/728
(98 %)
0 diff
(100 %id)
CA391365 eye, RPE/choroid .i 358 to 912 555 to 1     Submitted on the opposite strand 555/555
(100 %)
0 diff
(100 %id)
CD616715   .i 523 to 738 10 to 224       215/224
(95 %)
6 diff
(97.4 %id)
DA125273 cerebellum .j 1 to 427 2 to 429   tiling clone, capped   428/428
(100 %)
2 diff
(99.6 %id)
BF312524 brain, neuroblastoma .j 348 to 1188 2 to 838 D184E R192Q Q193A F194V A201P ... tiling clone,   837/975
(85 %)
8 diff
(99.2 %id)
BF316676 brain, neuroblastoma .j 348 to 1095 2 to 740   tiling clone,   739/743
(99 %)
17 diff
(97.8 %id)
BE312052 brain, neuroblastoma .j 367 to 919 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BE313811 brain, neuroblastoma .j 367 to 893 1 to 529       529/530
(99 %)
3 diff
(99.5 %id)
DA086061 cerebellum .k 1 to 579 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
AK308137 brain .k 213 to 2674 1 to 2481 E198V C199E I200R S201A L202P ... tiling clone,   2481/2481
(100 %)
13 diff
(99.5 %id)
NM_001144761.1   .k 213 to 2682 1 to 2490 E198V C199E I200R S201A L202P ... RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2490/2490
(100 %)
10 diff
(99.6 %id)
TI_57183284   .k 473 to 1096 33 to 675       643/675
(95 %)
17 diff
(97.5 %id)
BI769867 pooled lung and spleen .k 474 to 1096 1 to 642       642/642
(100 %)
11 diff
(98.3 %id)
CN274888 embryonic stem cells, DMSO-treated H9 cellline .k 505 to 1255 1 to 773       773/773
(100 %)
16 diff
(98.0 %id)
BG468200 adenocarcinoma cell line, colon .k 567 to 973 11 to 436       436/436
(100 %)
12 diff
(97.3 %id)
BM550215 astrocytoma grade IV, cell line, brain .k 571 to 1459 1 to 918       916/964
(95 %)
24 diff
(97.6 %id)
BM910517 astrocytoma grade IV, cell line, brain .k 572 to 1492 1 to 947       947/1019
(92 %)
23 diff
(97.8 %id)
DA491098 brain .k 609 to 1138 2 to 551   capped   550/550
(100 %)
10 diff
(98.2 %id)
BM835515 stomach .k 701 to 1334 1 to 634   tiling clone,   634/634
(100 %)
0 diff
(100 %id)
BI046416 prostate_normal .k 702 to 1262 12 to 599       595/599
(99 %)
19 diff
(96.9 %id)
DA844108 placenta .k 797 to 1346 2 to 571   capped   570/570
(100 %)
11 diff
(98.1 %id)
DA057320 cerebellum .k 800 to 1372 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BQ710515 Spleen .k 827 to 1562 1 to 761       761/860
(88 %)
19 diff
(97.8 %id)
CD616717   .k 861 to 1075 10 to 243       234/243
(96 %)
11 diff
(95.5 %id)
CD672187 eye, Iris .k 869 to 1376 1 to 528     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 528/528
(100 %)
11 diff
(98.0 %id)
BG982509 colon_normal .k 888 to 1202 16 to 330       315/330
(95 %)
11 diff
(96.7 %id)
BF852364 lung_normal .k 950 to 1376 433 to 9     Submitted on the opposite strand 425/433
(98 %)
0 diff
(100 %id)
CD616713   .k 960 to 1378 1 to 419       419/435
(96 %)
5 diff
(98.9 %id)
CD616714   .k 965 to 1330 405 to 43       363/410
(88 %)
3 diff
(99.3 %id)
BI045797 prostate_normal .k 1008 to 1363 360 to 5       356/360
(98 %)
2 diff
(99.5 %id)
BI046443 prostate_normal .k 1008 to 1444 441 to 5       437/441
(99 %)
0 diff
(100 %id)
BI046562 prostate_normal .k 1008 to 1382 378 to 3       376/378
(99 %)
1 diff
(99.8 %id)
BQ371731 prostate_normal .k 1010 to 1428 442 to 20       421/444
(94 %)
15 diff
(96.7 %id)
BI046568 prostate_normal .k 1059 to 1445 387 to 2       386/529
(72 %)
0 diff
(100 %id)
BE790517 lung, small cell carcinoma .k 1091 to 1952 1 to 854       854/916
(93 %)
30 diff
(96.8 %id)
BI046110 prostate_normal .k 1166 to 1442 283 to 7       277/283
(97 %)
0 diff
(100 %id)
AL133965 brain .k 1188 to 1758 1 to 572   tiling clone,   572/572
(100 %)
1 diff
(99.9 %id)
T49792 placenta .k 1334 to 1534 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
BU535664 adenocarcinoma, cell line, breast .k 1349 to 2141 3 to 799       797/887
(89 %)
15 diff
(98.4 %id)
BU956145 adenocarcinoma, cell line, breast .k 1349 to 2062 3 to 716       714/867
(82 %)
9 diff
(99.0 %id)
BG473997 eye, retinoblastoma .k 1492 to 2168 1 to 678       678/678
(100 %)
15 diff
(97.8 %id)
BG330349 large cell carcinoma, lung .k 1529 to 2326 1 to 810       809/913
(88 %)
27 diff
(97.1 %id)
CD616718   .k 1579 to 2337 766 to 7       760/766
(99 %)
6 diff
(99.3 %id)
CN274887 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 1596 to 2201 1 to 606   tiling clone,   606/606
(100 %)
3 diff
(99.6 %id)
CD616716   .k 1610 to 2337 734 to 7       728/734
(99 %)
5 diff
(99.4 %id)
BM852549 stomach .k 1628 to 2011 1 to 383       383/383
(100 %)
2 diff
(99.5 %id)
BM850780 stomach .k 1628 to 2064 1 to 437       437/437
(100 %)
0 diff
(100 %id)
AI909780 breast .k 1717 to 2155 442 to 3       438/488
(89 %)
11 diff
(97.8 %id)
TI_149285236   .k 1840 to 2674 904 to 88   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 817/1072
(76 %)
26 diff
(97.6 %id)
BM984768 lung .k 2052 to 2674 640 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 622/622
(100 %)
2 diff
(99.7 %id)
H64692 nose, olfactory epithelium .k 2079 to 2299 1 to 220       220/220
(100 %)
8 diff
(96.4 %id)
BE076381 breast .k 2166 to 2322 160 to 4     Submitted on the opposite strand 157/170
(92 %)
3 diff
(98.3 %id)
BG988616 head_neck .k 2178 to 2545 370 to 5   tiling clone,   366/370
(98 %)
0 diff
(100 %id)
T49793 placenta .k 2359 to 2649 291 to 1       291/320
(90 %)
8 diff
(97.5 %id)
H65186 nose, olfactory epithelium .k 2363 to 2417 55 to 1       55/56
(98 %)
1 diff
(98.3 %id)
AA975013 pooled .k 2363 to 2676 313 to 1       313/314
(99 %)
2 diff
(99.4 %id)
CA431711 Bone, Subchondral Bone .k 2363 to 2676 332 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 314/314
(100 %)
0 diff
(100 %id)
AW302369 brain, three pooled meningiomas .k 2365 to 2682 318 to 1   tiling clone,   318/318
(100 %)
0 diff
(100 %id)
H09772 whole brain .k 2366 to 2674 336 to 28       309/336
(91 %)
0 diff
(100 %id)
AW149276 brain, tumor, 5 pooled (see description) .k 2392 to 2676 287 to 1       287/287
(100 %)
11 diff
(96.2 %id)
CD672186 eye, Iris .k 2399 to 2676 294 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
AI420948 Prostate .k 2409 to 2677 271 to 3       269/271
(99 %)
0 diff
(100 %id)
DW427258 Liver .k 2423 to 2676 17 to 270       254/279
(91 %)
5 diff
(98.3 %id)
AI208059   .k 2426 to 2677 254 to 3       252/254
(99 %)
0 diff
(100 %id)
F31633 pectoral muscle (after mastectomy) .k 2438 to 2585 1 to 148       148/148
(100 %)
2 diff
(98.7 %id)
BQ005577 Chondrosarcoma, Left Pelvis .k 2449 to 2676 243 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 227/227
(100 %)
9 diff
(96.1 %id)
EC527781 Prostate .k 2465 to 2569 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
AI424260 Prostate .k 2468 to 2667 243 to 44   AAA   200/209
(95 %)
0 diff
(100 %id)
AI970957 Prostate .k 2511 to 2676 166 to 1       166/166
(100 %)
1 diff
(99.4 %id)
DC405067 thymus .l 1 to 559 1 to 559 I31L tiling clone,   559/559
(100 %)
1 diff
(99.9 %id)
DA918378 small intestine .m 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
DA396797 thalamus .n 1 to 580 10 to 589 exact tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
DA071502 cerebellum .o 1 to 578 2 to 579 exact tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DB264167 uterus .o 1 to 572 2 to 575 Y60H capped   574/579
(99 %)
4 diff
(99.4 %id)
DA083723 cerebellum .o 31 to 579 2 to 551 D26* capped   550/550
(100 %)
1 diff
(99.9 %id)
DA306983 hippocampus .o 31 to 607 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DA097749 cerebellum .o 64 to 645 2 to 583 exact capped   582/582
(100 %)
2 diff
(99.7 %id)
CA395209 eye, RPE/choroid .o 134 to 494 1 to 361       361/361
(100 %)
7 diff
(98.1 %id)
CA395198 eye, RPE/choroid .o 136 to 584 1 to 449       449/449
(100 %)
1 diff
(99.8 %id)
DA057754 cerebellum .o 586 to 1144 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DA297557 hippocampus .p 1 to 557 2 to 578 R76S V77G H78E L79S R81E ... tiling clone, capped   577/577
(100 %)
19 diff
(96.8 %id)
DB100356 testis .q 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
3 diff
(99.5 %id)
DA873984 Prostate .q 93 to 657 2 to 566   capped   565/565
(100 %)
5 diff
(99.2 %id)
CV574685 cornea, eye .q 504 to 1109 1 to 606   tiling clone,   606/606
(100 %)
0 diff
(100 %id)
BG913639 anaplastic oligodendroglioma with 1p/19qloss, brain .q 610 to 912 83 to 385       303/409
(74 %)
6 diff
(98.6 %id)
CD245594 White Matter .q 926 to 1658 1 to 740   tiling clone,   740/840
(88 %)
11 diff
(98.7 %id)
BQ933236 sciatic nerve .q 1065 to 1764 1 to 726       726/951
(76 %)
23 diff
(97.6 %id)
BI116934 lung, small cell carcinoma .q 1214 to 1761 1 to 567   tiling clone,   567/944
(60 %)
29 diff
(97.0 %id)
T28093 brain .q 1760 to 2090 1 to 331   tiling clone,   331/331
(100 %)
1 diff
(99.7 %id)
AA601575 pheochromocytoma .r-u 1 to 255 1 to 253   tiling clone, Submitted on the opposite strand 253/253
(100 %)
1 diff
(99.7 %id)
R24598 placenta .r-u 155 to 440 1 to 291   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 291/292
(99 %)
9 diff
(97.0 %id)
CB959268 Pooled-Glandular .r-u 339 to 650 1 to 312 L62P K64X tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 312/313
(99 %)
3 diff
(99.1 %id)
R24500 placenta .r-u 446 to 642 216 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 196/197
(99 %)
0 diff
(100 %id)
DA788674 brain .s 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
AI276234 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .s 307 to 552 271 to 25   AAA   247/247
(100 %)
14 diff
(94.4 %id)
N90257 parathyroid gland, parathyroid tumor .t-u 1 to 386 388 to 1 G40X Q41N R42G L43F H44T ... tiling clone,   388/388
(100 %)
5 diff
(98.8 %id)
BM955944 tonsil .u-u 1 to 160 1 to 160 exact tiling clone,   160/160
(100 %)
3 diff
(98.2 %id)
AK123183 cerebellum Gene TLE2, variant not shown       available from FLJ, This clone was ignored    
AK303102 thymus Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
DB298231 cerebellum Gene TLE2, variant not shown         This clone was ignored    
DA089001 cerebellum Gene TLE2, variant not shown       capped This clone was ignored    
BJ990240 hepatoblastoma Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
BJ990241 hepatoblastoma Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
AA593206 colon, colon tumor RER+ Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
AA879441 pooled Gene TLE2, variant not shown         This clone was ignored    
AI364365 anaplastic oligodendroglioma, brain Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
AI810917 Prostate Gene TLE2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF062872 colon, colon tumor, RER+ Gene TLE2, variant not shown         Suspected internal deletion, this clone was ignored    
BU538227 adenocarcinoma, cell line, breast Gene TLE2, variant not shown         This clone was ignored    
TI_149302619   Gene TLE2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM980776 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene TLE2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t-u, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI